Insufficient insulin production or action in diabetic states is associated with growth retardation and impaired bone healing, while the underling mechanisms are unknown. In this study, we sought to define the role of insulin signaling in the growth plate. Insulin treatment of embryonic metatarsal bones from wild-type mice increased chondrocyte proliferation. Mice lacking insulin receptor (IR) selectively in chondrocytes (CartIR 2/2 ) had no discernable differences in total femoral length compared to control littermates. However, CartIR 2/2 mice exhibited an increase in chondrocyte numbers in the growth plate than that of the controls. Chondrocytes lacking IR had elevated insulin-like growth factor (IGF)-1R mRNA and protein levels. Subsequently, IGF-1 induced phosphorylation of Akt and ERK was enhanced, while this action was eliminated when the cells were treated with IGF-1R inhibitor Picropodophyllin. Deletion of the IR impaired chondrogenic differentiation, and the effect could not be restored by treatment of insulin, but partially rescued by IGF-1 treatment. Intriguingly, the size of hypertrophic chondrocytes was smaller in CartIR 2/2 mice when compared with that of the control littermates, which was associated with upregulation of tuberous sclerosis complex 2 (TSC2). These results suggest that deletion of the IR in chondrocytes sensitizes IGF-1R signaling and action, IR and IGF-1R coordinate to regulate the proliferation, differentiation and hypertrophy of growth plate chondrocytes.
INTRODUCTION
The insulin-like growth factors (IGFs) evolved in lower animals to enable a wide range of physiological processes, including smell, food consumption, metabolism, growth, reproduction and dormancy. [1] [2] These functions were accomplished by the actions of multiple-related ligands that activated a common transmembrane receptor protein. 3 In higher organisms including mammals, the insulin and IGF ligands and their receptors diverged and evolved more circumscribed functions. The contemporary view is that IGFs serve dominant roles in cell proliferation, survival and organismal growth, whereas insulin's primary functions include the regulation of fuel accumulation, storage and energy expenditure. 1 However, such a simplistic model tends to obscure the fact that insulin and IGF-1 continue to perform overlapping roles in several physiological processes. A compelling body of circumstantial evidence suggests that IGF/IGF-1R and insulin/insulin receptor (IR) serve overlapping functions in selected tissues including the skeleton. 4 In both humans and mice, loss of IGF-1 action is manifested with severe intrauterine growth retardation and delayed bone development. [5] [6] [7] Mice with conditional deletion of IGF-1 in chondrocytes have reduced bone accretion during postnatal bone growth. 8 Humans with mutations in the IR (Leprechaunism) exhibit profound growth retardation, 9 which resembles those seen in mice with engineered mutations of the IR. 10 The growth plate of the IR mutant mouse embryo exhibits a profound developmental delay in the appearance of ossification centers and severe growth deficiency (30% of normal size at birth). 10 Comparison of the phenotype of these IR-deficient mice with those of IGF-1R knockout mice suggests that IR and IGF-1R have distinct, but partially overlapping, physiological functions. [11] [12] Mice lacking IGF-1R specifically in chondrocytes exhibit a shorter and narrower growth plate, and the size of individual hypertrophic chondrocytes appeared smaller compared to that of control 1 littermates. 13 Both the IR and IGF-1R are expressed and appear to be functional in chondrogenic cells. [14] [15] However, the cellular targets and molecular mechanisms through which insulin/IR signaling functions to regulate chondrogenesis during skeletal development and following injury are unknown. Chondrogenesis is regulated by multiple mechanisms including systemic or local factors emanating from the surrounding matrix, inflammatory mediators, cytokines and various growth factors. Key among these are transforming growth factor-beta, 16 IGF-1, 17 fibroblast growth factors 18 and PTHrP/Indian hedgehog, which together coordinate the pace of chondrocyte proliferation and differentiation. 13 Distinguishing the skeletal effects of insulin from those of IGF-1 in vivo is complicated by the fact that most cell types express both IR and IGF-1R, as well as IR/IGF-IR hybrid receptors, which can be cross-activated by the others receptor's ligand. 19 In addition, because the signaling pathways downstream from IR and IGF-IR share many components, the characterization of these signaling events may not distinguish which receptor is initiating the signal. 20 To circumvent these problems, we generated mice selectively lacking IR in chondrocytes through crossbreeding of the mouse strain carrying the IR-floxed allele 21 and the mouse strain carrying Cre recombinase under the control of collagen type II promoter. 22 In vivo, CartIR
mice demonstrated alterations in growth plate development characterized by an increase in the overall numbers of chondrocytes and a reduction in size of cells in the hypertrophic zone. In vitro loss of IR impaired chondrogenic differentiation and reduced proteoglycan synthesis; these abnormalities could not be rescued by treatment of insulin. Interestingly, IR-deficient chondrocytes had increased IGF-1R levels and were more responsive to IGF-1 consistent with the notion that IGF-1/IGF-1R may compensate, at least in part, for loss of IR signaling. Fetal mouse metatarsal culture Metatarsal bone culture was performed following the previously published method. 25 In brief, E17.5 embryos were removed from timed-pregnant mice, and metatarsals were dissected. The isolated metatarsals were cultured in 24-well culture plates in 150 mL of DMEM supplemented with 10% heat-inactivated fetal bovine serum and 1% of penicillin/streptomycin and 1% L-glutamine for 72 h. Two hundred and fifty microliters of fresh medium were then replaced with or without insulin or IGF-1. The metatarsal bones were cultured for 6 days with replacement of medium every 3 days. The total length of metatarsal bones was measured in each specimen. The proliferating, hypertrophic and mineralizing zones were also measured in the H&E-stained sections. The proliferation of chondrocytes was determined by immunostaining for PCNA in the metatarsal bone sections.
MATERIALS AND METHODS

Reagents
Western blot analysis Western blotting analysis was performed using standard protocol. Briefly, whole-cell lysate was obtained by cell lysis buffer in the presence of a protease inhibitor cocktail (Sigma-Aldrich). Equal amount of protein was loaded onto an SDS mini-PAGE system after concentrations were determined, and transferred onto a PVDF membrane using a Bio-Rad semidry transfer system. Protein transfer efficiency and size determination were verified using prestained protein markers. Membranes were blocked with 5% dry milk in Tris-buffered saline Tween-20 for 1 h at room temperature and subsequently incubated overnight with primary antibodies at 4 6 C. Signals were detected using an HRP-conjugated secondary antibody and the SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Thermo Fisher Scientific, Inc., Rockford, IL, USA).
Quantitative real-time PCR Total RNA was extracted from cells using the Trizol method as recommended by the manufacturer (Invitrogen). The RNA concentration was estimated by spectrophotometer and only pure RNA (A 260 /A 280 ratio $1.8) was used for further analysis. First strand cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad). The cDNA was amplified in the Opticon Continuous Fluorescent Detector (MJ Research, Waltham, MA, USA) using IQTM SYBR Green supermix (Bio-Rad) and sequence specific primers. PCRs were performed in triplicate for each cDNA, averaged, and normalized to endogenous actin reference transcripts. Primer sequences used were listed in Table 1 Chondrocytes proliferation and apoptosis assay The mutant or control chondrocytes were plated in six-well plates with the density of 1 310 5 , and cultured in medium with 1% serum for 24 h and then were restimulated with insulin (10 nmol?L
21
) for an additional 24 h before harvest. For proliferation analysis, BrdU was added to the medium 12 h before harvesting the cells. The cells were then stained for anti-BrdU-APC and 7-amino-actinomycin D following the manufacturer's instructions (BD Biosciences). For the apoptosis assay, annexin V-PE (BD Biosciences) and 7-amino-actinomycin D were used for staining. Cells were analyzed by FACSCalibur (BD Biosciences) and 20 000 events were collected. The results were analyzed with ModFit LT 3.3 software.
Statistical analysis For comparison of cellular and tissue parameters between the wild-type and mutant mice, the statistical analysis was performed using the Microsoft Excel data analysis program for Student's t-test analysis. For comparisons among multiple groups, the analysis of variance was used. All of the experiments were repeated at least three times unless otherwise stated. The values are expressed as the means6standard deviation (s.d.). A significance level was defined as P,0.05.
RESULTS
Insulin promotes growth of fetal metatarsal cultures To begin to examine the effects of insulin on chondrocytes, we determined the effects of insulin and IGF-1 on the growth of fetal metatarsal rudiments in vitro. Metatarsal bones from E17.5 wild-type mouse embryos were cultured for 6 days in the absence or presence of 10 nmol?L 21 insulin or 13 nmol?L 21 IGF-1. Both ligands significantly increased the total length (Figure 1a and 1b) primarily by increasing the lengths and numbers of cells in the proliferating zone (Figure 1c and 1d) . Immunostaining for PCNA also showed that treatment with insulin and IGF-1 increased PCNA positive cell numbers in the cultured metatarsal bone sections (Figure 1e and 1f ). These data demonstrate that insulin exerts mitogenic effects in growth plate chondrocytes that are qualitatively similar to those of IGF-1.
Alterations in growth plate development in CartIR 2/2 mice
To determine the importance of insulin signaling on growth plate development in vivo, we generated mice deficient in IR in chondrocytes as described in the section on 'Materials and methods'. Immunostaining for IR showed an efficient elimination of IR in chondrocytes of the growth plates in CartIR the different zones of the growth plates indicated that the proliferating zone of the growth plate was modestly increased while the prehypertrophic zone was decreased in CartIR 2/2 mice compared to controls (Figure 2e and 2f) .
No significant change was observed at the hypertrophic zone (Figure 2g ). Histological analysis revealed that CartIR 2/2 mice had a significant increase in the total number of chondrocytes in all regions of the growth plate (Figure 2h-j) . In addition, compared to controls, CartIR 2/2 mice showed an increase in the number of PCNA-positive chondrocytes in the proliferating zone (Figure 2k and 2l) and a reduction in size of hypertrophic chondrocytes (Figure 2m and 2n) .
Disruption of IR impairs differentiation of chondrocytes in vitro
We next examined the effect of deletion of IR on chondrogenic differentiation in primary chondrocytes. Monolayers were infected with either Ad-GFP or Ad-Cre (100 MOI) and efficiency of the IR deletion was verified by measuring IR mRNA and protein expression 48 h after infection (Figure 3a and 3b) . Chondrocytes lacking IR grown in micromass culture demonstrated a reduction in Alcian Blue staining that persisted even when cells were cultured in the presence of 10 nmol?L 21 insulin, which was partially restored by the treatment of IGF-1 (Figure 3c ). These changes were accompanied by marked reductions in expression of Sox9 and collagen type 10 mRNA levels (Figure 3d and 3e) . in osteoblasts lacking IGF-1R 12 . In accordance with this notion, the expression of IGF-1R increased following disruption of IR (Figure 4a ) and increased IGF-1R levels were detected in growth plate chondrocytes from CartIR 2/2 mice (Figure 4b and 4c) . In addition, expression of IGF-1 and IGF-2 mRNA increased following acute deletion of IR in primary chondrocytes (Figure 4d and 4e) . Moreover, chondrocytes lacking IR had higher basal and IGF-1 induced Akt and ERK phosphorylation compared to control cells (Figure 4f and 4g) . The apparent increase in sensitivity to IGF-1 was dependent on a functional IGF-1R since as IGF-1 induced Akt and ERK phosphorylation was markedly attenuated by the treatment with PPP (Figure 4f phospho-ERK and total ERK (g). Quantitation of the ratios of phospho-Akt to total Akt and phospho-ERK to total ERK was shown. Actin as the loading control. IGF-1, insulin-like growth factor-1; PPP, picropodophyllin. (h, i) Cell proliferation rate was assessed by flow cytometry following BrdU incorporation (h). *P,0.05, n53. Apoptosis was assessed by flow cytometry using annexin V-PE staining (i). P.0.05, n53.
the effect of disruption of IR on chondrocyte proliferation. As shown in Figure 4h , both IGF-1 and insulin increased BrdU incorporation in GFP expressing cells. However, in cells lacking IR, IGF-1 further increased BrdU incorporation, whereas the effect of insulin was diminished as expected. By contrast, deletion of the IR did not significantly affect apoptosis of chondrocytes with or without IGF-1 or insulin treatment (Figure 4i ). Collectively, these results suggest the presence of a common mechanism for overlapping functional redundancy in IGF and insulin signaling pathways and may explain our observation of persistent increased proliferation in growth plate chondrocytes from mice lacking IR.
Decreased hypertrophic cell size is associated with increased TSC2 To begin to address the mechanisms for the decreased size of the hypertrophic chondrocytes in the CartIR
mice, we determined the expression of TSC1 and TSC2 proteins in chondrocytes. In drosophila, TSC1/TSC2 complex acts to antagonize insulin signaling and negatively regulate cell growth and size. 26 In primary chondrocytes, basal levels of TSC2 protein were increased following disruption of IR, whereas TSC1 protein levels were unchanged (Figure 5a ). Treatment with IGF-1 modestly increased TSC2 levels to a similar extent in control and IRdeficient cells. In accord with these results, TSC2 protein levels determined immunohistochemically were higher in hypertrophic chondrocytes of the CartIR 2/2 mice compared to controls (Figure 5b ). These results indicate that the IR signaling may be necessary to regulate cellular size and growth of hypertrophic chondrocytes during growth plate development at least partially mediated by TSC2.
DISCUSSION
In the present study, we used the Cre-loxP technique to remove IR from chondrocytes, which has enabled us to determine the contribution of insulin signaling through its cognate receptor. We show that the loss of IR signaling causes upregulation of IGFs and IGF-1R, which appear to act in a compensatory fashion to regulate the proliferation and hypertrophy of chondrocytes.
The present results obtained in using fetal metatarsals and isolated chondrocytes in vitro clearly show that insulin can increase the proliferation of this cell type. Because these experiments used relatively low insulin concentrations that would not be expected to cross-activate the IGF-1R, we attribute these mitogenic actions to signaling through IR. Consistent with this finding, deletion of IR in cultured chondrocytes abolished the mitogenic activity of insulin. The mitogenic activity of insulin is conserved across species and has been previously reported in growth plate chondrocytes from the fetal lamb 15 . Surprisingly, however, the CartIR 2/2 mice exhibited increased PCNApositive chondrocytes in all regions of the developing growth plate. Based on the fact that IR and IGF-1R are abundantly expressed in chondrocytes [27] [28] and the previous work which showed upregulation of IR signaling in osteoblasts lacking IGF-1R, 12 we suspected that the increased proliferation of IR-deficient growth plate chondrocytes could be caused by upregulation of the IGF-1/ IGF-1R signaling pathway. In keeping with this idea, IR-deficient chondrocytes demonstrated increased production of IGF-1 and IGF-2, and greater responsibility to IGF-1 the later due in part to increased expression of IGF-1R. These findings suggest the presence of a compensatory pathway present in cells expressing both IR and IGF-1R through which loss of insulin generated signals triggers increased signaling via IGF-1/IGF-1R. Such a mechanism would account for the preservation of relatively normal postnatal growth of the CartIR 2/2 mice.
Another striking feature of the growth plate in CartIR 2/2 mice was the decreased size of chondrocytes in the hypertrophic zone, suggesting a normal role for insulin in regulation of chondrocyte size. Previous studies have established a role for the conserved insulin signaling pathway in regulating cell and organ size in a number of species. In Drosophila, inactivation of positive regulators of insulin signaling (e.g., IR, IRS-1-4) decreases cell size, whereas overexpression of these components has the opposite effect. [29] [30] Insulin induces these effects by controlling the activity of the conserved TOR complex, 31 which transduces insulin signals to control cell growth, size, polarity and metabolism [32] [33] [34] through its ability to sense prevailing nutrient and energy levels. A critical component of this sensor is conferred by the TSC, which inhibits mTOR activity 35 and to control the strength of insulin-generated signals according to the energy status of the cell. Thus, loss of TSC2 increases cells size and overexpression of the protein decreases cells size. 26 Our finding of increased TSC2 levels in hypertrophic chondrocytes from the CartIR 2/2 mice is entirely consistent with loss of insulin signaling through mTOR and likely accounts for the smaller size of these chondrocytes. These data support a normal role for insulin signaling, as a determinant of chondrocyte size, which is apparently cannot compensated by local upregulation of IGF-1/IGF-1R. In summary, our studies demonstrate that insulin/IR signaling induces direct, IGF-1R-independent, actions on growth plate chondrocytes, which are necessary for them to proliferate, differentiate and achieve their final size. Our findings expand understanding of physiological role of insulin/IR in the skeleton and suggest the importance of future studies to examine insulin action under pathological conditions such as impaired bone healing associated with diabetes.
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